Corpus Intelligence IC Memo — PIONEER MEMORIAL HOSPITAL AND HEALTH 2026-04-26 11:19 UTC
IC Memo — PIONEER MEMORIAL HOSPITAL AND HEALTH
Investment Committee Memorandum | SD | 12 beds | Grade D | EBITDA uplift $854K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

PIONEER MEMORIAL HOSPITAL AND HEALTH

CCN 431328 | TURNER, SD | 12 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

PIONEER MEMORIAL HOSPITAL AND HEALTH is a 12-bed rural/critical access in TURNER, SD with $11.5M in net patient revenue and a -5.5% operating margin. The hospital serves a payer mix of 60.1% Medicare, 2.0% Medicaid, and 37.8% commercial.

Thesis: Turnaround. Our ML models identify $854K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -5.5% to 1.9% (+740bps).

Net Revenue HCRIS$11.5M
Current EBITDA COMPUTED$-640K
Operating Margin COMPUTED-5.5%
Occupancy HCRIS12.4%
Revenue / Bed COMPUTED$962K
Net-to-Gross HCRIS69.2%
Distress Probability ML61.9%

2. Market Context & Competitive Position

63
SD Hospitals
-3.2%
State Median Margin
20
Comparable Hospitals

SD has 63 Medicare-certified hospitals with a median operating margin of -3.2%. The target's margin of -5.5% places it below the state median. Among 20 size-comparable peers (6-24 beds), the median margin is -1.1%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (6-24), prioritizing same-state peers. 20 hospitals in the comp set.

HospitalStateBedsRevenueMargin
PIONEER MEMORIAL HOSPITAL AND (Target)SD12$11.5M-5.5%
MADISON REGIONAL HEALTH SYSTEMSD22$33.8M-1.6%
MONUMENT HEALTH CUSTER HOSPITASD12$27.8M-7.3%
MONUMENT HEALTH LEAD-DEADWOOD SD18$20.2M-0.6%
PHILIP HEALTH SERVICES INCSD18$17.6M1.9%
AVERA GREGORY HOSPITALSD13$17.5M-23.5%
PLATTE HEALTH CENTER INC.SD17$17.1M2.4%
WAGNER COMMUNITY MEMORIAL HOSPSD20$14.2M-1.5%
SSH - SIOUX FALLS INCSD24$13.6M16.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $854K (740bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$242K+210bp18mo
Cost to Collect4.5%2.5%$231K+200bp12mo
Denial Rate Reduction12.0%6.5%$231K+200bp12mo
A/R Days Reduction5200.0%3800.0%$141K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+8bp6mo

5. EBITDA Bridge

Net Collection Rate
$242K
Cost to Collect
$231K
Denial Rate Reduction
$231K
A/R Days Reduction
$141K
Clean Claim Rate
$10K
Total EBITDA Uplift$854K
Current EBITDA$-640K
+ RCM Uplift+$854K
Pro Forma EBITDA$214K
Current Margin-5.5%
Pro Forma Margin1.9%
WC Released (1x)$443K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-985K$4.3M0.00x-100.0%
Base (11x exit)10.0x11.0x$-985K$4.4M0.00x-100.0%
Bull Case9.0x11.0x$-887K$6.9M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-887K$7.3M0.00x-100.0%
Bear Case11.0x10.0x$-1.1M$367K0.00x-100.0%
Bear (11x exit)11.0x11.0x$-1.1M$51K0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumHeavy Medicare dependenceMedicare comprises 60.1% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement
MediumLow occupancyAt 12.4%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 61.9% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 20 hospitals with 6-24 beds
  • Same-state prioritization (n=26)
  • Comp margins: P25=-11.8% / P50=-1.1% / P75=5.1%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.